Found 31 clinical trials
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected with Chronic HCV who have Advanced Liver Disease or are Post-Liver Transplant
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected with Chronic HCV who
- 444 views
- 08 Nov, 2020
- 1 location
Interferon and Ribavirin Treatment in Patients With Hemoglobinopathies
safety of combination therapy with pegylated interferon and ribavirin in thalassemic patients. This study is carried ahead to assess the impact of combination therapy with pegylated-interferon
- 0 views
- 07 Nov, 2020
- 1 location
IFN Beta-1b and Ribavirin for Covid-19
ribavirin combination treatment for patients hospitalized for COVID-19 infection.
- 0 views
- 24 Jan, 2021
- 1 location
RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin
The aim of this study is to compare two therapeutical strategies concerning the combination therapy (peginterferon alfa-2a and ribavirin) in naïve patients with chronic hepatitis C of
- 14 views
- 07 Nov, 2020
- 1 location
Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels
Patients with chronic hepatitis C with persistently normal alanine aminotransferase (ALT) levels have been generally excluded from treatment, because the strong conviction that normal ALT would be synonymous of absence of liver damage. However, recent studies have demonstrated marked liver fibrosis, including cirrhosis, in patients with HCV and persistently normal …
- 7 views
- 07 Nov, 2020
- 1 location
Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders
This study aims to assess the role of ribavirin as an adjuvant to sofosbuvir/velpatasvir/voxilaprevir combination in retreatment of chronic hepatitis C with previous treatment failure.
- 0 views
- 28 Jan, 2021
- 1 location
The Pharmacokinetics of P1101 + Ribavirin in Interferon Treatment-Na ve Subjects With Chronic HCV Genotype 2 Infection
Primary Objective: To determine the P1101 PK profile at the single dose of 400 g.
- 0 views
- 08 Mar, 2021
- 5 locations
Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients
genotype 1-4 co-infected with HIV-HCV, treated with Peginterferón alfa-2a (40 KD) 180 µg/week and Ribavirin (2000 mg/day during 4 weeks, follow of 1000-1200 mg/day, according to body weight
- 10 views
- 07 Nov, 2020
- 38 locations
Vitamin D Treatment in Patients With Chronic Hepatitis C
Ribavirin, there will be an increase in their sustained virological response.
- 10 views
- 07 Nov, 2020
- 1 location
Liver Test Study of Using JKB-122 in HCV-Positive Patients
been nonresponsive to, intolerable to, or relapsed from prior interferon-based therapies (pegylated or standard) either alone or in combination with ribavirin or other anti-HCV therapies
- 24 views
- 07 Nov, 2020
- 4 locations